These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 16109659

  • 1. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD, Bid HK, Ghoshal UC.
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [Abstract] [Full Text] [Related]

  • 2. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yaouanq J, Bretagne JF, Semana G.
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [Abstract] [Full Text] [Related]

  • 3. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
    Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Peña AS.
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
    Vijgen L, Van Gysel M, Rector A, Thoelen I, Esters N, Ceelen T, Vangoidsenhoven E, Vermeire S, Rutgeerts P, Van Ranst M.
    Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621
    [Abstract] [Full Text] [Related]

  • 5. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Celik Y, Dagli U, Kiliç MY, Törüner M, Ozen SC, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Bozdayi AM.
    Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698
    [Abstract] [Full Text] [Related]

  • 6. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J, Subrt I, Dìdek P, Siala K, Schwarz J, Machalová V, Varvarovská J, Pazdiora P, Pozler O, Stozický F.
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [Abstract] [Full Text] [Related]

  • 7. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, Göke B, Folwaczny C, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [Abstract] [Full Text] [Related]

  • 8. Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
    Glas J, Stallhofer J, Ripke S, Wetzke M, Pfennig S, Klein W, Epplen JT, Griga T, Schiemann U, Lacher M, Koletzko S, Folwaczny M, Lohse P, Göke B, Ochsenkühn T, Müller-Myhsok B, Brand S.
    Am J Gastroenterol; 2009 Jul; 104(7):1737-44. PubMed ID: 19455118
    [Abstract] [Full Text] [Related]

  • 9. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD, Manchanda PK, Bid HK, Ghoshal UC.
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [Abstract] [Full Text] [Related]

  • 10. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
    Chen B, Zeng Z, Hou J, Chen M, Gao X, Hu P.
    Scand J Gastroenterol; 2009 Jun; 44(6):720-6. PubMed ID: 19263269
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
    Saibeni S, Spina L, Virgilio T, Folcioni A, Borsi G, de Franchis R, Cugno M, Vecchi M.
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):976-81. PubMed ID: 18049167
    [Abstract] [Full Text] [Related]

  • 12. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
    Haas SL, Andreas Koch W, Schreiber S, Reinhard I, Koyama N, Singer MV, Böcker U.
    Scand J Gastroenterol; 2005 Dec; 40(12):1438-43. PubMed ID: 16316892
    [Abstract] [Full Text] [Related]

  • 13. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
    Weersma RK, Oostenbrug LE, Nolte IM, Van Der Steege G, Oosterom E, Van Dullemen HM, Kleibeuker JH, Dijkstra G.
    Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
    [Abstract] [Full Text] [Related]

  • 14. [The significance of IL-13 gene +2044G/A mutation in patients with inflammatory bowel disease].
    Waterman M, Karban A, Nesher S, Weiss B, Shamir R, Eliakim R.
    Harefuah; 2006 Nov; 145(11):789-92, 864. PubMed ID: 17183946
    [Abstract] [Full Text] [Related]

  • 15. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease.
    Manzoli A, Andreotti F, Varlotta C, Mollichelli N, Verde M, van de Greef W, Sperti G, Maseri A.
    Cardiologia; 1999 Sep; 44(9):825-30. PubMed ID: 10609392
    [Abstract] [Full Text] [Related]

  • 16. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y, Matsumoto K, Negoro K, Takagi S, Takahashi S, Hiwatashi N, Shimosegawa T.
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [Abstract] [Full Text] [Related]

  • 17. Is interleukin-6 important in inflammatory bowel disease?
    Koss K, Satsangi J, Welsh KI, Jewell DP.
    Genes Immun; 2000 Feb; 1(3):207-12. PubMed ID: 11196713
    [Abstract] [Full Text] [Related]

  • 18. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M, Kappler R, Berkholz S, Baurecht H, von Schweinitz D, Koletzko S.
    Biochem Biophys Res Commun; 2007 Nov 23; 363(3):701-7. PubMed ID: 17892861
    [Abstract] [Full Text] [Related]

  • 19. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
    Bid HK, Manchanda PK, Mittal RD.
    Urology; 2006 May 23; 67(5):1099-104. PubMed ID: 16698387
    [Abstract] [Full Text] [Related]

  • 20. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
    Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP.
    Genes Immun; 2000 Feb 23; 1(3):185-90. PubMed ID: 11196710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.